Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present United Therapeutics Corp. (NASDAQ: UTHR).

Full DD Report for UTHR

You must become a subscriber to view this report.


Recent News from (NASDAQ: UTHR)

Healthcare And Biotechnology Dashboard - Update
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology is undervalued regarding historical averages, but profitability measu...
Source: SeekingAlpha
Date: November, 06 2018 11:32
Nilda Mesa Joins The United Therapeutics Corporation Board Of Directors
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Nov. 1, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Nilda Mesa to its Board of Directors as an independent director. The appointment is effective as of October 31, 20...
Source: PR Newswire
Date: November, 01 2018 06:00
United Therapeutics (UTHR) Q3 2018 Results - Earnings Call Transcript
United Therapeutics Corp. (UTHR) Q3 2018 Earnings Call October 31, 2018 9:00 am ET Executives James Christopher Edgemond - United Therapeutics Corp. Martine A. Rothblatt - United Therapeutics Corp. Michael Benkowitz - United Therapeutics Corp. Analysts Chris Shibutani - Cow...
Source: SeekingAlpha
Date: October, 31 2018 15:19
United Therapeutics down 6% on Q3 results
Thinly traded United Therapeutics ( UTHR -6.4% ) is down on average volume after posting Q3 results that were consistently down from a year ago. Highlights: More news on: United Therapeutics Corporation, Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read...
Source: SeekingAlpha
Date: October, 31 2018 12:30
Gilead down 6% as investors unmoved with Tango deal
Gilead Sciences ( GILD -5.7% ) slumps on average volume. Investors appear disappointed with the (lack of) potential for its immuno-oncology partnership with Tango to rekindle growth. More news on: Gilead Sciences, Inc., United Therapeutics Corporation, Healthcare stocks news, Stocks on t...
Source: SeekingAlpha
Date: October, 31 2018 12:16
United Therapeutics beats by $0.95, beats on revenue
United Therapeutics (NASDAQ: UTHR ): Q3 Non-GAAP EPS of $3.98 beats by $0.95 ; GAAP EPS of $2.42 misses by $0.61 . More news on: United Therapeutics Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 31 2018 06:03
United Therapeutics Corporation Reports Third Quarter 2018 Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Oct. 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the quarter ended September 30, 2018. "We are pleased to see continued growth in the number of U.S. pati...
Source: PR Newswire
Date: October, 31 2018 06:00
Notable earnings before Wednesday's open
ACOR , ADP , AEE , AIT , ANTM , APO , APTV , ARCC , AUO , BAX , BCOR , BDC , BG , CAMT , CBZ , CDW , CG , CIM , CLH , CLX , CRTO , CVE , DBD , DIN , EGL , EL , EPD , ETR , GM , GNC , GRMN , HCP , HES , HFC , HSC , IART , ICE , ICPT , IGT , K , LFUS ,...
Source: SeekingAlpha
Date: October, 30 2018 17:30
MannKind: Scripts, Cash, And Quarterly Calls
MannKind (MNKD) investors are in for an interesting week. Afrezza scripts came in essentially flat for the week ending October 19th, and we should see a cash infusion of $45 million relating to the United Therapeutics (UTHR) deal. On top of that, United Therapeutics is scheduled to have a qua...
Source: SeekingAlpha
Date: October, 30 2018 06:04
Why MannKind Warrants Are Important
With the news that MannKind ( MNKD ) inked a deal with United Therapeutics ( UTHR ), MannKind's stock rose and long term investors who have suffered through the last few years saw a new breath of hope around this equity. The purpose of this article is not to take the proverbial wind out of t...
Source: SeekingAlpha
Date: September, 11 2018 08:39

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-14122.99124.52125.19122.58238,626
2017-03-10146.10148.56149.09146.1063,088
2017-03-09147.45146.44149.15145.04342,016
2017-03-08145.77146.97149.07145.77487,658
2017-03-07145.34144.99147.09144.15492,949

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1423,92178,09030.6326Cover
2018-12-1312,18142,37128.7484Cover
2018-12-1223,34984,79627.5355Cover
2018-12-1135,157133,61626.3120Cover
2018-12-1017,43147,25636.8863Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on UTHR.


About United Therapeutics Corp. (NASDAQ: UTHR)

Logo for United Therapeutics Corp. (NASDAQ: UTHR)

Not available

 

Contact Information

 

 

Current Management

  • Martine A. Rothblatt / CEO

Current Share Structure

  • Market Cap: $4,627,423,218 - 05/18/2018
  • Issue and Outstanding: 43,544,022 - 04/25/2018

 


Recent Filings from (NASDAQ: UTHR)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 28 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: June, 28 2018

 

 


Daily Technical Chart for (NASDAQ: UTHR)

Daily Technical Chart for (NASDAQ: UTHR)


Stay tuned for daily updates and more on (NASDAQ: UTHR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: UTHR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in UTHR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of UTHR and does not buy, sell, or trade any shares of UTHR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/